Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2400.0000 (-3.03%) ($2255.0000 - $2475.0000) on Mon. Sep. 22, 2008. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.22% (three month average) | | RSI | 61 | | Latest Price | $2400.0000(-3.03%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -0.6% a day on average for past five trading days. | | Weekly Trend | CAPR advances 0.1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | | Factors Impacting CAPR price | CAPR will decline at least -1.61% in a week (0% probabilities).
EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.61% (StdDev 3.22%) | | Hourly BBV | 0 () | | Intraday Trend | -3% | | | | | |
|
| Resistance Level | $2462.15 | | 5 Day Moving Average | $2475(-3.03%) | | 10 Day Moving Average | $2474.67(-3.02%) | | 20 Day Moving Average | $2462.15(-2.52%) | | To recent high | -8.6% | | To recent low | 27.3% | | Market Cap | $47.274b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |